New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
18:05 EDTZTSZoetis could climb 25%, Barron's says
Zoetis (ZTS) isn't subject to the same patent expiration cliff as Pfizer (PFE) and earnings should rise 13% over the next few years, Barron's says in its "Weekday Trader" column. Shares could climb 25%, the paper adds. Reference Link
News For ZTS From The Last 14 Days
Check below for free stories on ZTS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 23, 2014
09:00 EDTZTSBofa/Merill special situations team to hold an analyst/industry conference call
Subscribe for More Information
September 19, 2014
07:35 EDTZTSZoetis seen as potential Bayer target after split announcement, Bloomberg says
Subscribe for More Information
September 17, 2014
07:43 EDTZTSBofA/Merrill to hold a conference
Subscribe for More Information
September 10, 2014
11:05 EDTZTSZoetis downgraded to Long-Term Buy from Buy at Hilliard Lyons

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use